Global Dental Turbine Market Research Report (2021 to 2027) - by Product Type, Turbine Speed, End User and Region

News provided by

Mar 21, 2022, 11:45 ET

DUBLIN, March 21, 2022 /PRNewswire/ -- The "Dental Turbine Market Research Report by Product Type, by Turbine Speed, by End User, by Region - Global Forecast to 2027 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering.

The Global Dental Turbine Market size was estimated at USD 104.02 million in 2020, is expected to reach USD 115.71 million in 2021, and is projected to grow at a CAGR of 11.59% to reach USD 224.27 million by 2027.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2027 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Dental Turbine to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Product Type, the market was studied across Air Driven Turbines, Electric Turbines, and Hybrid Air-Electric Turbines.
Based on Turbine Speed, the market was studied across High-Speed Dental Turbines and Low-Speed Dental Turbines.
Based on End User, the market was studied across Dental Clinics and Hospitals.
Based on Region, the market was studied across the Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Dental Turbine Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Dental Turbine Market, including AbbVie, Inc., Allergan PLC, Astellas Pharma Inc., AstraZeneca PLC, Bayer AG, Biocon Limited, Bristol-Myers Squibb Company, Celldex Therapeutics, Inc., Celltrion, Inc., Eli Lilly and Company, Emcure Pharmaceuticals Ltd., F. Hoffman-La Roche Pvt. Ltd, G1 Therapeutics, Inc., Janssen Global Services, LLC, MacroGenics Inc., Merck & Co., Inc., Novartis AG, Pfizer Inc., Takeda Pharmaceutical Company Limited, and Teva Pharmaceutical Industries Ltd..

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Global Dental Turbine Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Dental Turbine Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Dental Turbine Market?
4. What is the competitive strategic window for opportunities in the Global Dental Turbine Market?
5. What are the technology trends and regulatory frameworks in the Global Dental Turbine Market?
6. What is the market share of the leading vendors in the Global Dental Turbine Market?
7. What modes and strategic moves are considered suitable for entering the Global Dental Turbine Market?

Key Topics Covered:

1. Preface

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing number of patients having dental implants and history of periodontitis
5.1.1.2. Advent of technological advancements pertaining to the dental procedure
5.1.1.3. Rise in behavioral risk factors like smoking and diabetes
5.1.2. Restraints
5.1.2.1. High cost of surgical treatment
5.1.3. Opportunities
5.1.3.1. Growing oral health awareness with the rising disposable income
5.1.3.2. Rising demand for cosmetic dentistry
5.1.4. Challenges
5.1.4.1. Risk of infection in a dental setting
5.2. Cumulative Impact of COVID-19

6. Dental Turbine Market, by Product Type
6.1. Introduction
6.2. Air Driven Turbines
6.3. Electric Turbines
6.4. Hybrid Air-Electric Turbines

7. Dental Turbine Market, by Turbine Speed
7.1. Introduction
7.2. High-Speed Dental Turbines
7.3. Low-Speed Dental Turbines

8. Dental Turbine Market, by End User
8.1. Introduction
8.2. Dental Clinics
8.3. Hospitals

9. Americas Dental Turbine Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Dental Turbine Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand

11. Europe, Middle East & Africa Dental Turbine Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. AbbVie, Inc.
13.2. Allergan PLC
13.3. Astellas Pharma Inc.
13.4. AstraZeneca PLC
13.5. Bayer AG
13.6. Biocon Limited
13.7. Bristol-Myers Squibb Company
13.8. Celldex Therapeutics, Inc.
13.9. Celltrion, Inc.
13.10. Eli Lilly and Company
13.11. Emcure Pharmaceuticals Ltd.
13.12. F. Hoffman-La Roche Pvt. Ltd
13.13. G1 Therapeutics, Inc.
13.14. Janssen Global Services, LLC
13.15. MacroGenics Inc.
13.16. Merck & Co., Inc.
13.17. Novartis AG
13.18. Pfizer Inc.
13.19. Takeda Pharmaceutical Company Limited
13.20. Teva Pharmaceutical Industries Ltd.

14. Appendix

For more information about this report visit https://www.researchandmarkets.com/r/x5hrla

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets